Candida parapsilosis is a significant neonatal pathogen: a systematic review and meta-analysis
- PMID: 23340551
- PMCID: PMC3681839
- DOI: 10.1097/INF.0b013e3182863a1c
Candida parapsilosis is a significant neonatal pathogen: a systematic review and meta-analysis
Abstract
Background: Candida is the third most common cause of late-onset neonatal sepsis in infants born at <1500 g. Candida parapsilosis infections are increasingly reported in preterm neonates in association with indwelling catheters.
Methods: We systematically reviewed neonatal literature and synthesized data pertaining to percentage of C. parapsilosis infections and mortality by meta-analyses. We also reviewed risk factors, virulence determinants, antimicrobial susceptibility patterns and outlined clinical management strategies.
Results: C. parapsilosis infections comprised 33.47% (95% confidence interval [CI]: 30.02, 37.31) of all neonatal Candida infections. C. parapsilosis rates were similar in studies performed before the year 2000, 33.53% (95% CI: 30.06, 37.40) (28 studies), to those after 2000, 27.00% (95% CI: 8.25, 88.37) (8 studies). The mortality due to neonatal C. parapsilosis infections was 10.02% (95% CI: 7.66, 13.12). Geographical variations in C. parapsilosis infections included a low incidence in Europe and higher incidence in North America and Australia. Biofilm formation was a significant virulence determinant and predominant risk factors for C. parapsilosis infections were prematurity, prior colonization and catheterization. Amphotericin B remains the antifungal drug of choice and combination therapy with caspofungin or other echinocandins may be considered in resistant cases.
Conclusion: C. parapsilosis is a significant neonatal pathogen, comprises a third of all Candida infections and is associated with 10% mortality. Availability of tools for genetic manipulation of this organism will identify virulence determinants and organism characteristics that may explain predilection for preterm neonates. Strategies to prevent horizontal transmission in the neonatal unit are paramount in decreasing infection rates.
Figures




Similar articles
-
Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.Cochrane Database Syst Rev. 2016 Jan 16;2016(1):CD004920. doi: 10.1002/14651858.CD004920.pub3. Cochrane Database Syst Rev. 2016. PMID: 26772902 Free PMC article.
-
Identification and antifungal resistance profiling of Candida (Candidozyma) auris in a tertiary hospital in Istanbul, Türkiye.Ann Saudi Med. 2025 Jul-Aug;45(4):207-217. doi: 10.5144/0256-4947.2025.207. Epub 2025 Aug 7. Ann Saudi Med. 2025. PMID: 40753464 Free PMC article.
-
Population-based longitudinal study over two decades of Candida and Candida-like species bloodstream infection reveals gender and species differences in mortality, recurrence and resistance.J Infect. 2025 Jul;91(1):106513. doi: 10.1016/j.jinf.2025.106513. Epub 2025 May 22. J Infect. 2025. PMID: 40412444
-
Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children.Cochrane Database Syst Rev. 2010 Nov 10;2010(11):CD003940. doi: 10.1002/14651858.CD003940.pub3. Cochrane Database Syst Rev. 2010. PMID: 21069679 Free PMC article.
-
Patient isolation measures for infants with candida colonization or infection for preventing or reducing transmission of candida in neonatal units.Cochrane Database Syst Rev. 2007 Jul 18;(3):CD006068. doi: 10.1002/14651858.CD006068.pub2. Cochrane Database Syst Rev. 2007. Update in: Cochrane Database Syst Rev. 2011 Nov 09;(11):CD006068. doi: 10.1002/14651858.CD006068.pub3. PMID: 17636825 Updated.
Cited by
-
Epidemiology and risk factors of candidemia due to Candida parapsilosis in an intensive care unit.Rev Inst Med Trop Sao Paulo. 2021 Mar 24;63:e20. doi: 10.1590/S1678-9946202163020. eCollection 2021. Rev Inst Med Trop Sao Paulo. 2021. PMID: 33787740 Free PMC article.
-
Treatment with Micafungin in a Preterm Neonate with an Invasive Candida parapsilosis Infection after a Severe Terlipressin-Induced Skin Necrosis.Pathogens. 2021 Jul 13;10(7):890. doi: 10.3390/pathogens10070890. Pathogens. 2021. PMID: 34358040 Free PMC article.
-
Neonatal Brain Abscess with Serratia marcescens after Intrauterine Infection: A Case Report.Antibiotics (Basel). 2023 Apr 7;12(4):722. doi: 10.3390/antibiotics12040722. Antibiotics (Basel). 2023. PMID: 37107084 Free PMC article.
-
Analysis of clinical Candida parapsilosis isolates reveals copy number variation in key fluconazole resistance genes.Antimicrob Agents Chemother. 2024 Jun 5;68(6):e0161923. doi: 10.1128/aac.01619-23. Epub 2024 May 7. Antimicrob Agents Chemother. 2024. PMID: 38712935 Free PMC article.
-
Candida parapsilosis: an emerging pathogen developing its own identity.Virulence. 2015;6(2):109-11. doi: 10.1080/21505594.2015.1008897. Virulence. 2015. PMID: 25668388 Free PMC article. No abstract available.
References
-
- Stoll BJ, Hansen N, Fanaroff AA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics. 2002;110:285–291. - PubMed
-
- Wisplinghoff H, Bischoff T, Tallent SM, et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39:309–317. - PubMed
-
- Brito LR, Guimaraes T, Nucci M, et al. Clinical and microbiological aspects of candidemia due to Candida parapsilosis in Brazilian tertiary care hospitals. Med Mycol. 2006;44:261–266. - PubMed
-
- Krcmery V, Barnes AJ. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J Hosp Infect. 2002;50:243–260. - PubMed